Moreover, the treatment with an anti-IL-20 monoclonal antibody effectively hindered HCC cell proliferation, migration, and invasion in vitro and demonstrated the suppression of liver tumor growth in vivo [139]. Here, IL20 is linked to hepatocellular carcinoma.